Buy NORDITROPIN FLEXPRO 15MG/1.5ML (45IU)
NORDITROPIN FLEXPRO 15MG is prefilled and premixed. This means you don’t have to load the growth hormone with cartridges Users of Norditropin Flexpro Pen have access to NordiCare patient support, which can help you with Norditropin Flexpro Pen 45IU insurance issues you may have Norditropin Flexpro Pen offers multiple doses which means most patients can use the pen several times before the medicine runs out.
Buy NORDITROPIN FLEXPRO 15MG is indicated for the treatment of children with growth failure due to inadequate secretion of endogenous growth hormone, the treatment of children with short stature associated with Noonan syndrome or Turner syndrome, the treatment of children with short stature born small for gestational age (SGA) with no catch-up growth by age 2-4 years.
Side effects NORDITROPIN FLEXPRO 15MG
Side effects that you should report to your doctor or health care professional as soon as possible:
• allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
• back curves to the side
• breathing problems
• changes in vision
• dark urine
• ear pain or infection
• lumpy, thinning skin at site where injected
• nausea, vomiting
• pain in hip or knee
• swelling of the feet or hands
• unusually weak or tired
Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):
• bone or muscle pain
• hair loss
• pain and swelling at site where injected
How to use
Weight Based Regimen:
Initial dose: Not more than 0.004 mg/kg subcutaneously once a day.
Maximum dose: 0.016 mg/kg once a day (0.08 mg/kg per week in divided doses)
Non-Weight Based Regimen:
Approximately 0.2 mg subcutaneously once a day (range: 0.15 to 0.3 mg once a day)
-The weekly dose should be divided over 6 or 7 days of subcutaneous injections.
-May increase dose (weight or non-weight based) at 4 to 8 week intervals, by increments of approximately 0.1 to 0.2 mg per day (not more than 0.004 mg/kg per day), based on clinical response and serum IGF-I concentrations.
-The dose should be decreased as necessary on the basis of adverse events and/or serum IGF-I concentrations above the age- and gender-specific normal range.
-Maintenance dosages vary considerably from person to person, and between male and female patients.
-Obese individuals are more likely to manifest adverse effects when treated with a weight-based regimen. -To reach the defined treatment goal, estrogen-replete women may need higher doses than men.
How to Store
Keep NORDITROPIN FLEXPRO 15MG out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the package after EXP/. The expiry date refers to the last day of that month.
Store unused Norditropin Flexpro cartridges in a refrigerator (2°C – 8°C) in the outer carton, in order to protect from light. Do not freeze or expose to heat.
While using Norditropin Flexpro 15mg/1.5 ml cartridge in an injection pen you can either:
- Keep it in the pen for up to 4 weeks in a refrigerator (2°C – 8°C), or
- Keep it in the pen for up to 3 weeks at room temperature (below 25°C).
Do not continue to use Norditropin Flexpro cartridges if they have been frozen or exposed to excessive temperatures.
Check each new NORDITROPIN FLEXPRO 15MG cartridge before you use it. Do not use any cartridge that is damaged or cracked.
Do not use Norditropin Flexpro cartridges if the solution inside is cloudy or discoloured.